EUVIMED · CrossrefZeitschrift
Metabolism and Target Organ Damage
ISSN 2769-6375 · OAE Publishing Inc.
Neueste Artikel
Semaglutide after metabolic and bariatric surgery: advancing treatment for suboptimal weight loss and weight regain
Glucose transporters in health and disease: from molecular mechanisms to therapeutic applications
Lean MAFLD as a distinct phenotype
Advances in the non-invasive assessment of metabolic dysfunction-associated steatotic liver disease
Fibroblast growth factor 19/15-mediated metabolic regulation supports its drug development potential: a narrative review
Lipid-associated macrophages in metabolic dysfunction-associated steatotic liver disease: immune regulation of lipid burden
Alterations in the serum lipid profile predict incident diabetes in obese individuals
Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions
Beyond the liver: targeting the hepatic microenvironment and multi-organ networks for innovative MASH therapy
Validation of EASO criteria and development of a new diagnostic tool for visceral obesity in Chinese adults
Causal relationships among seven cardiovascular-associated metabolic diseases: insights from a bidirectional Mendelian randomization study
Lipid metabolism in liver transplantation: from challenge to chance
Evolving models of care in patients with metabolic dysfunction-associated steatotic liver disease, recognising its population burden and the impact of metabolic dysfunction on incident rates of hepatic and extrahepatic outcomes
Metrnl plays a crucial role in the regulation of glycolipid metabolism
A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease
Insulin increases type I collagen synthesis in hepatic stellate cells via α5β1 integrin
Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways
Diabetes mellitus and heart disease
The relationship between hyperuricemia and hypertension: a short review of current evidence
Chronic obstructive pulmonary disease (COPD) and metabolic fatty liver syndromes: a dangerous but neglected liaison
Colon cancer in a 12-year-old girl with hypertriglyceridemia
MAFLD AND NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality?
Sarcopenia in the setting of nonalcoholic fatty liver
Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system
Liver transplantation and nonalcoholic steatohepatitis: the state of the art
Metabolism and cancer-select topics
Assessing strategies to target screening for advanced liver fibrosis among overweight and obese patients
Liver-derived lipoproteins and inflammation: from pathophysiology to pharmacological targets in metabolic liver disease
EUVIMED